Your session is about to expire
← Back to Search
Hyperbaric Oxygen Therapy for Long COVID (PCS-HBOT Trial)
PCS-HBOT Trial Summary
This trial is exploring a new treatment for post COVID-19 symptoms, such as fatigue, using hyperbaric oxygen therapy. The findings could help decide if this treatment is feasible for a large-scale research study.
PCS-HBOT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPCS-HBOT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PCS-HBOT Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research initiative currently recruiting participants?
"Contrary to what was previously thought, information from clinicaltrials.gov reveals that this medical study is not recruiting at the present moment. The trial initially opened its doors on October 1st 2023 and had a final edit made on October 12th 2023. Fortunately for patients searching for trials, there are 2325 other studies actively looking for participants right now."
What is the fundamental purpose of this experiment?
"Over the course of 9 months, this clinical trial will measure patient recruitment rate as its primary outcome. Subsidiary objectives include gauging hyperbaric oxygen therapy's effect on post-COVID fatigue (with Fatigue Severity Scale) and quality of life (via SF-36), with a comparison between immediate HBOT treatments versus delayed ones using PDQ scales."
Share this study with friends
Copy Link
Messenger